Zhejiang University: Esophageal Neoplasms trials
The registry lists 13 Esophageal Neoplasms studies with Zhejiang University as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 5Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT07791979Not applicable
- High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea PatientsRecruitingNCT07307560Not applicable
- Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese PatientsRecruitingNCT07175155Not applicable
- Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated GastroscopyRecruitingNCT07104214
- COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical TrialRecruitingNCT06796764Not applicable
- The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1RecruitingNCT05829057Phase 1
- High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea PatientsCompletedNCT07155330Not applicable
- Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese PatientsCompletedNCT06812403Phase 2
- Low-dose Aspirin Therapy for Esophageal CancerWithdrawnNCT02326779Phase 3
- Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02041819Phase 2
- Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWithdrawnNCT02034968Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal CarcinomaWithdrawnNCT02011594Phase 2